Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective β1-adrenoreceptor blocker Talinolol

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 5, 2012, Pages 618-626

  Ghai, Damanjeet ^a   Sinha, Vivek Ranjan ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apparent permeability (Papp); Droplet size; Oral talinolol loaded nanoemulsion; Permeability flux; Self nanoemulsifying drug delivery systems (SNEDDS)

Indexed keywords

APPARENT PERMEABILITY (PAPP); CONVENTIONAL EMULSIONS; DROPLET SIZES; DRUG DELIVERY CARRIER; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUTIONS; DRUG SUSPENSIONS; ENHANCED PERMEABILITY; ETHANOLIC SOLUTION; GUT SAC; IN-VIVO; NANO-EMULSIONS; NANO-SIZED; NANOEMULSION; POLYDISPERSITY INDICES; POORLY WATER-SOLUBLE DRUGS; PSEUDOTERNARY PHASE DIAGRAMS; TRIACETIN;

BIOCHEMISTRY; DROPS; DRUG DELIVERY; EMULSIFICATION; PHASE DIAGRAMS;

DRUG PRODUCTS;

ALCOHOL; BRIJ 721; TALINOLOL; TRIACETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; MALE; MAXIMUM PLASMA CONCENTRATION; NANOEMULSION; NONHUMAN; RAT; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; SURFACE PROPERTY; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; INTESTINES; MALE; NANOPARTICLES; ORGAN CULTURE TECHNIQUES; PERMEABILITY; PROPANOLAMINES; RATS; RATS, WISTAR; SOLUBILITY; SURFACE PROPERTIES; SWINE;

RATTUS; SUS;

EID: 84862658209     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.08.015     Document Type: Article

References (28)

1. Lin SL, Menig J, Lachman L Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water-insoluble drugs. J Pharm Sci 1968, 57:2143-2148.
2. El-Banna HM, Daabis NA, El-Fattah SA Aspirin stability in solid dispersion binary system. J Pharm Sci 1978, 67:1631-1633.
3. Hasegawa A, Nakagawa H, Sugimoto I Bioavailability and stability of Nifedipine-enteric coating agent solid dispersion. Chem Pharm Bull 1985, 33:388-391.
4. Pouton CW Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000, 11:S93-S98.
5. Pouton CW Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006, 29:278-287.
6. Holm R, Porter CJH, Edwards GA, Müllertz A, Kristensen HG, Charman WN Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003, 20:91-97.
7. Araya H, Nagao S, Tomita M, Hayashi M The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type o/w microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. Drug Metab Pharmacokinet 2005, 20:244-256.
8. Wakerly MG, Pouton CW, Meakin BJ, Morton FS Self-emulsification of vegetable oil-nonionic surfactant mixtures: a proposed mechanism of action. ACS Symp Ser 1986, 311:242-255.
9. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm Res 1992, 9:87-93.
10. Craig DQM, Lievens HSR, Pitt KG, Storey DE An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurement and particle size analysis. Int J Pharm 1993, 96:147-155.
11. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994, 106:15-23.
12. Devain M, Ashford M, Craig DQM The emulsification and solublisation properties of polyglycolysed oils in self-emulsifying formulations. J Pharm Pharmacol 2004, 56:307-316.
13. Porter CJ, Charman WN In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 2001, 50:S127-S147.
14. Erkko P, Granlund H, Nuutinen M, Reitamo S Comparison of cyclosporine A pharmacokinetics of a new microemulsion formulation and standard oral preparation in oatients with psoriasis. Br J Dermatol 1997, 136:82-88.
15. Keng BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle digs. Int J Pharm 2004, 274:65-73.
16. Wagner D, Glube N, Berntsen N, Tremel W, Langguth P Different dissolution media lead to different crystal structures of talinolol with impact on its dissolution and solubility. Drug Dev Ind Pharm 2003, 29:891-902.
17. Patel D, Sawant KK Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm 2007, 33:1318-1326.
18. Sinha VR, Ghai D Design and evaluation of talinolol loaded self-nano emulsifying drug delivery systems (SNEDDS). Tata McGraw Hill Education Private Limited. New Delhi, India. Proceedings of International Conference on Nanoscience and technology in Chemistry, Health, Environment and Energy, Agra, India, 7-9 January 2010, 222-228. L.D. Khemani, S. Dass (Eds.).
19. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Sci 2007, 66:227-243.
20. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007, 8:E1-9.
21. Grove M, Mullertz A, Nielsenc JL, Pedersen GP Bioavailability of seocalcitol II: development and characterization of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 2006, 28:233-242.
22. Legen I, Salobir M, Kerc J Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm 2005, 291:183-188.
23. Tubic M, Wagner D, Spahn-Langguth H, Weiler C, Wanitschke R, Bocher WO, et al. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. Eur J Pharm Sci 2006, 29:231-239.
24. Sinha VR, Ghai D RP-HPLC stability-indicating assay method for talinolol and characterization of its degradation products. J Chromat Sci 2011, 49:786-795.
25. Lawrence MJ, Rees GD Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000, 45:89-121.
26. Nielsen FS, Petersen KB, Mullertz A Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Sci 2008, 69:553-562.
27. Narang AS, Delmarre D, Gao D Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007, 345:9-25.
28. Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci. 2006;128-130:47-64.